Mississippi · 2026 Regular Session · Bill
HB 1667: Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 1667 is a bill introduced in the Mississippi House on January 19, 2026. According to its official title, it concerns: Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs. Primary sponsor: Mark Tullos (Republican). Most recent recorded action (February 3, 2026): Died In Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Mark Tullos | Primary sponsor | Republican | House | 79 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died In Committee
- Referred To State Affairs